Skip to main content
Signal8

Lobe Sciences Ltd. (LOBEF)

Lobe Sciences Ltd. is a life sciences company focused on researching and advancing psychedelic-based medicines. Their primary therapeutic development involves psilocybin-derived treatments combined with N-acetylcysteine, specifically for addressing mild traumatic brain injuries (mTBI) and post-traumatic stress disorder (PTSD). Additionally, they engineer specialized devices aimed at enhancing the efficiency of drug administration. This organization, headquartered in Vancouver, Canada, underwent a name change from Greenstar Biosciences Corp. to Lobe Sciences Ltd. in November 2020.

Sector: Biotechnology

Industry: Biotechnology

Lobe Sciences Ltd. logo

Lobe Sciences Ltd.

OTC:LOBEFHealthcare
-2.43%$0.0346
CLOSED
Mkt Cap$10.66M
EV-
Float83.08M
O/S308.18M
VOL1K sh
$ Vol$35
RVOL0.01×
Inst Own-
SI0.1%
Net Cash/Sh-
Dilution
Lobe Sciences Ltd. logoOTC:LOBEFClosed$0.0346-2.43%
FormDescription
    Lobe Sciences Ltd. (LOBEF) SEC Filings: 10-K, 10-Q, 8-K | Signal8